80.65
전일 마감가:
$82.31
열려 있는:
$82.48
하루 거래량:
3.47M
Relative Volume:
0.99
시가총액:
$36.76B
수익:
$20.63B
순이익/손실:
$2.15B
주가수익비율:
17.71
EPS:
4.5546
순현금흐름:
$1.51B
1주 성능:
+2.13%
1개월 성능:
-7.01%
6개월 성능:
+15.28%
1년 성능:
-8.92%
Ge Healthcare Technologies Inc Stock (GEHC) Company Profile
명칭
Ge Healthcare Technologies Inc
전화
833-735-1139
주소
500 WEST MONROE STREET, CHICAGO
Compare GEHC vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
GEHC
Ge Healthcare Technologies Inc
|
80.65 | 37.51B | 20.63B | 2.15B | 1.51B | 4.5546 |
|
ABT
Abbott Laboratories
|
110.83 | 189.68B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
358.29 | 138.60B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
102.90 | 131.98B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
76.27 | 115.14B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.71 | 45.32B | 5.88B | 1.34B | 799.60M | 2.3489 |
Ge Healthcare Technologies Inc Stock (GEHC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-15 | 다운그레이드 | UBS | Neutral → Sell |
| 2025-10-13 | 개시 | Barclays | Equal Weight |
| 2025-10-07 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-05-05 | 업그레이드 | UBS | Sell → Neutral |
| 2025-03-11 | 업그레이드 | Goldman | Neutral → Buy |
| 2025-01-08 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-09-26 | 다운그레이드 | UBS | Neutral → Sell |
| 2024-09-18 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2024-09-09 | 개시 | JP Morgan | Neutral |
| 2024-08-06 | 개시 | Stifel | Buy |
| 2024-05-30 | 개시 | Goldman | Neutral |
| 2024-02-15 | 개시 | HSBC Securities | Buy |
| 2024-02-12 | 업그레이드 | UBS | Sell → Neutral |
| 2023-11-30 | 개시 | Jefferies | Hold |
| 2023-11-27 | 다운그레이드 | UBS | Neutral → Sell |
| 2023-09-19 | 개시 | Citigroup | Buy |
| 2023-08-25 | 개시 | Argus | Buy |
| 2023-08-16 | 개시 | Wells Fargo | Overweight |
| 2023-07-31 | 개시 | BofA Securities | Neutral |
| 2023-06-27 | 개시 | Morgan Stanley | Equal-Weight |
| 2023-05-16 | 개시 | Oppenheimer | Outperform |
| 2023-04-26 | 개시 | UBS | Neutral |
| 2023-04-19 | 개시 | Piper Sandler | Overweight |
| 2023-04-10 | 개시 | BTIG Research | Neutral |
| 2023-03-13 | 개시 | Evercore ISI | Outperform |
| 2023-02-17 | 개시 | Mizuho | Buy |
| 2023-01-19 | 개시 | Redburn | Buy |
모두보기
Ge Healthcare Technologies Inc 주식(GEHC)의 최신 뉴스
GE HealthCare Technologies Inc. (NASDAQ:GEHC) Yearly Results: Here's What Analysts Are Forecasting For This Year - simplywall.st
BNP Paribas Adjusts Price Target on GE Healthcare Technologies to $95 From $92, Maintains Outperform Rating - marketscreener.com
Are Wall Street Analysts Bullish on GE HealthCare Technologies Stock? - Yahoo Finance
Wells Fargo Remains a Buy on GE Healthcare Technologies Inc (GEHC) - The Globe and Mail
GE Healthcare announced a collaboration with Diagnoly to advance the use of artificial intelligence in fetal ultrasound assessments - marketscreener.com
A Look At GE HealthCare Technologies (GEHC) Valuation After Earnings Update And Allia Moveo Approvals - Sahm
Barclays Adjusts Price Target on GE Healthcare Technologies to $87 From $86, Maintains Equalweight Rating - marketscreener.com
GE HealthCare Technologies Inc (GEHC) Shares Gap Down to $82.63 on Feb 5 - GuruFocus
GE HealthCare, Diagnoly collab on AI-driven fetal ultrasound - MassDevice
Piper Sandler Adjusts Price Target on GE Healthcare Technologies to $96 From $94, Maintains Overweight Rating - marketscreener.com
Wells Fargo Adjusts Price Target on GE Healthcare Technologies to $97 From $95, Maintains Overweight Rating - marketscreener.com
Goldman Sachs Adjusts GE Healthcare Technologies PT to $97 From $98, Maintains Buy Rating - marketscreener.com
GE HealthCare Technologies Inc. (NASDAQ:GEHC) Q4 2025 Earnings Call Transcript - Insider Monkey
GE HealthCare Technologies Pops, And The Upside Isn't Over Yet (NASDAQ:GEHC) - Seeking Alpha
GEHC Q4 Deep Dive: Product Pipeline and Service Recurring Revenue Drive Outlook - The Globe and Mail
EXACT Therapeutics: Exercise of Warrants by GE Medical Holding AB - The Manila Times
GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan, from Sumitomo Chemical - intellectia.ai
EXACT Therapeutics: Exercise of Warrants by GE Medical Holding AB - GlobeNewswire Inc.
GE HealthCare Technologies Inc. (GEHC) Shares Rise as Robust 2026 Outlook Offsets Tariff-Driven Margin Squeeze - AlphaStreet News -
Decoding GE HealthCare Technologies Inc (GEHC): A Strategic SWOT Insight - GuruFocus
GE HealthCare’s (NASDAQ:GEHC) Q4 CY2025: Beats On Revenue - The Globe and Mail
GE HealthCare Technologies Is Quietly Exploding – Here’s What Wall Street Isn’t Telling You - AD HOC NEWS
GE HealthCare: Q4 Earnings Snapshot - theheraldreview.com
Is GE HealthCare Technologies (GEHC) Offering Value After Recent Share Price Weakness - Yahoo Finance
GE HealthCare Earnings Call: Growth Amid Tariff Strain - TipRanks
GE HealthCare stock price target raised to $91 from $87 at BTIG - Investing.com UK
Does GE HealthCare’s 2025 Beat And AI Push Reshape The Bull Case For GEHC? - Yahoo Finance
GE HealthCare Q4 2025 slides: organic growth persists despite tariff headwinds - Investing.com Australia
GE HealthCare Stock Rises. Earnings Were a Relief. - Barron's
GE HealthCare expects 8–12% EPS growth and $1.7B free cash flow in 2026 as new products ramp - MSN
GE HealthCare stock price target raised to $91 from $87 at BTIG By Investing.com - Investing.com Australia
GE HealthCare Technologies Q4 2025 Earnings Highlights - intellectia.ai
BTIG Research Adjusts GE Healthcare Technologies PT to $91 From $87, Maintains Buy Rating - marketscreener.com
GE HealthCare reports FY25 revenue of $20.6bn amid strong imaging demand - Yahoo Finance
GE HealthCare Technologies Inc (GEHC) Stock Price Up 5.97% on Fe - GuruFocus
GEHC: BTIG Raises Price Target to $91, Maintains Buy Rating | GE - GuruFocus
Tranche Update on GE HealthCare Technologies Inc.'s Equity Buyback Plan announced on April 30, 2025. - marketscreener.com
GE HealthCare Q4 Earnings and Revenues Beat Estimates, Net Margin Falls - Yahoo Finance
GE HealthCare Technologies Stock Climbs 5% Over Revenue Growth In Q4 - Nasdaq
GE HealthCare (GEHC) Q4 2025 Earnings Transcript - The Globe and Mail
Earnings call transcript: GE HealthCare’s Q4 2025 reveals steady growth By Investing.com - Investing.com India
Earnings call transcript: GE HealthCare’s Q4 2025 reveals steady growth - Investing.com
Compared to Estimates, GE HealthCare (GEHC) Q4 Earnings: A Look at Key Metrics - Yahoo Finance
GE HealthCare's (NASDAQ:GEHC) Q4 CY2025: Beats On Revenue - Finviz
GE HealthCare rises after Q4 beat, outlook (GEHC:NASDAQ) - Seeking Alpha
GE HealthCare Technologies (GEHC) Q4 Earnings and Revenues Beat Estimates - Yahoo Finance
GE HealthCare forecasts 2026 profit above estimates on strong demand for medical devices - Yahoo Finance
Human-Impact Story Reinforces GE HealthCare Oncology Focus - TipRanks
GE HealthCare Techs Q4 Earnings Summary & Key Takeaways - Benzinga
GE HealthCare Technologies (GEHC) Valuation Check As Earnings Near And Allia Moveo Launch Gains Attention - Yahoo Finance
GE HealthCare Techs: Q4 Earnings Insights - Benzinga
Ge Healthcare Technologies Inc (GEHC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):